Ignite Creation Date:
2024-05-06 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03611868
Status:
RECRUITING
Last Update Posted:
2024-02-01
First Post:
2018-07-27
Brief Title:
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-07-27
First Submit QC Date:
July 27 2018
Study First Post Date:
2018-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-17
Last Update Post Date:
2024-02-01
Last Update Post Date Type:
ACTUAL